UBS Group’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

UBS Group’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,000	Closed	-$246K	–	8273
2017 Q4	$246K	Buy	+13,000	New	+$235K	﹤0.01%	4774
2015 Q1	–	Sell	-100	Closed	-$1K	–	9544
2014 Q4	$1K	Buy	+100	New	+$735	﹤0.01%	9568

UBS Group's SPPI Position: Q3 2023 in Review

UBS Group sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 3,725 shares — an estimated $3.58K sold.

UBS Group first reported a position in SPPI in Q4 2014 and held it in 35 quarters. The position peaked at $5.13M in Q3 2018. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

UBS Group reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
UBS Group sold 3,725 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $3.58K.
UBS Group first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 35 quarters.
UBS Group's Spectrum Pharmaceuticals Inc position peaked at $5.13M in Q3 2018.
0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.